Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, Thomas W.·2005·Nature Reviews Immunology
DOI 10.1038/nri1602

Cited by (741)

Items 501–600 of 741

  1. Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures
    Laura Romina Caltana, Bernd Heimrich, Alicia Brusco · 2015 · Journal of Molecular Neuroscience
  2. Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion
    Melanie B. Elliott, Sara Jane Ward, Mary E. Abood, Ronald F. Tuma, Jack Jallo · 2017 · Concussion
  3. Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
    Ross T. Cromarty, Derseree Archary · 2020 · AIDS Research and Treatment
  4. Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
    Priscila Augusta Lima, Bárbara Betônico Berg, Marina Gomes Miranda e Castor · 2022 · Intestinal Research
  5. Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation
    Hamid A. Bakshi, Faruck Lukmanul Hakkim, Zeinab Ravesh, Prawej Ansari, J. M. A. Hannan, Rina Hashimoto, Kazuo Takayama, Rabia Farzand, Mohamed M. Nasef, Adelaide Mensah et al. · 2022 · Integrative Cancer Therapies
  6. Proteomic Changes in Methicillin-Resistant Staphylococcus aureus Exposed to Cannabinoids
    Jan Struckmann Poulsen, Christina Kjærager Nielsen, Nina Ahrendt Pedersen, Reinhard Wimmer, Teis Esben Søndergaard, Nadieh de Jonge, Jeppe Lund Nielsen · 2023 · Journal of Natural Products
  7. Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone
    Simone Di Micco, Tania Ciaglia, Emanuela Salviati, Perrone Michela, Magdalena Kostrzewa, Simona Musella, Aniello Schiano Moriello, Veronica Di Sarno, Gerardina Smaldone, Francesca Di Matteo et al. · 2024 · European Journal of Medicinal Chemistry
  8. Cannabinoids for the Treatment of Movement Disorders
    Briony J. Catlow, Juan Sanchez‐Ramos · 2015 · Current Treatment Options in Neurology
  9. Regulatory Effect of Cannabinoid Receptor Agonist on Chemokine-Induced Lymphocyte Chemotaxis
    Takashi Tanikawa, Kohta Kurohane, Yasuyuki Imai · 2011 · Biological and Pharmaceutical Bulletin
  10. Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists
    Karin Worm, Damian G. Weaver, Rosalyn C. Green, Christopher T. Saeui, Doreen-Marie S. Dulay, William M. Barker, Joel A. Cassel, Gabriel J. Stabley, Robert N. DeHaven, Christopher J. LaBuda et al. · 2009 · Bioorganic & Medicinal Chemistry Letters
  11. Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
    Anna Capasso · 2017 · The Open Neurology Journal
  12. Tetrahydrocannabinol and Skin Cancer: Analysis of YouTube Videos
    Andrina Mamo, Mindy D Szeto, Roya Brooke Mirhossaini, Andrew P Fortugno, Robert Paul Dellavalle · 2021 · JMIR Dermatology
  13. Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?
    Estrella Garcia-Gonzalez, Mauro Galeazzi, Enrico Selvi · 2016 · PubMed
  14. Système cannabinoïde et douleur : vers de nouveaux médicaments ?
    Massimiliano Beltramo · 2009 · Journal de la Société de Biologie
  15. Response to: “The role of cannabinoids in dermatology”
    Walter J. Liszewski, Ronda S. Farah · 2017 · Journal of the American Academy of Dermatology
  16. Poly(cannabinoid)s: Hemp-Derived Biocompatible Thermoplastic Polyesters with Inherent Antioxidant Properties
    Robert Daniels, Erick Orozco Morato, Omer A. Yassin, Jiahao Mao, Zeynep Mutlu, Mayank Jain, Joseph Valenti, Mükerrem Çakmak, Lakshmi S. Nair, Gregory Allen Sotzing · 2022 · ACS Applied Materials & Interfaces
  17. Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis -BCG by inhibiting NF-κB signaling
    Jessica do Prado Valeriano, Magaiver Andrade-Silva, Filipe Santos Pereira-Dutra, Leonardo Noboru Seito, Patrícia Torres Bozza, Elaine Cruz Rosas, Maria Fernanda de Souza Costa, Maria das Graças Henriques · 2024 · Journal of Leukocyte Biology
  18. Cannabis Use is Associated With Reduced 30-Day All-cause Readmission Among Hospitalized Patients With Irritable Bowel Syndrome
    Catherine Choi, Marwan Abougergi, Heather Peluso, Stanley H. Weiss, Umair Nasir, Nikolaos Pyrsopoulos · 2021 · Journal of Clinical Gastroenterology
  19. The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis
    Wessam Mustafa, Nadia Elgendy, Samer Salama, Mohamed Jawad, Khaled Eltoukhy · 2021 · Multiple Sclerosis International
  20. Cannabinoids in the Orthopedic Setting: A Literature Review
    Dominic S. Carreira, Steven R. Garden, Allison Huffman, Thomas E. Ueland · 2022 · Orthopedics
  21. Enzymatic inhibitive determination of AB-Fubinaca and AB-Pinaca on screen printed carbon tetratiofulvalene electrodes modified with nanoparticles and carbon nanotubes
    Julián Portuguez Brenes, Luis Arroyo, Miriam Barquero-Quirós · 2022 · Sensing and Bio-Sensing Research
  22. Augmented cannabinoid receptors expression in human aortic valve stenosis
    Yoshiro Naito, Takeshi Tsujino, Hirokuni Akahori, Mitsumasa Ohyanagi, Masataka Mitsuno, Yuji Miyamoto, Tohru Masuyama · 2010 · International Journal of Cardiology
  23. Cannabinoids and sepsis
    Nadia Ladak, Lucy Beishon, Jonathan P. Thompson, David George Lambert · 2011 · Trends in Anaesthesia and Critical Care
  24. Association Between Interleukin-6 and Neurocognitive Performance as a Function of Self-Reported Lifetime Marijuana Use in a Community Based Sample of African American Adults
    Larry Keen, Arlener D. Turner · 2014 · Journal of the International Neuropsychological Society
  25. Cannabinoids in Autoimmune and Rheumatic Diseases
    Luca Navarini, Domenico Paolo Emanuele Margiotta, Gabriele Gallo Afflitto, Antonella Afeltra · 2019 · Elsevier eBooks
  26. Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A
    Midori Kojima, Naoto Kato, Daisuke Hirano, Takashi Ochi, Aisuke Nii, Katsuhiro Shinjo, Hiroyuki Eda · 2008 · Hepatology Research
  27. El sistema cannabinoide y su importancia en el período perinatal
    José Antonio Martínez-Orgado, Digna López, B. Bonet Serra, Ignacio Lizasoaín, J. Romero Paredes · 2005 · Anales de Pediatría
  28. Water modulated influence of intramolecular hydrogen-bonding on the conformational properties of Cannabidiol (CBD)
    Aneta Buczek, Kacper Rzepiela, Małgorzata Anna Broda, Teobald Kupka, Birgit Strodel, Hebah Fatafta · 2025 · Journal of Molecular Liquids
  29. Region-Specific Impact of Repeated Synthetic Cannabinoid Exposure and Withdrawal on Endocannabinoid Signaling, Gliosis, and Inflammatory Markers in the Prefrontal Cortex and Hippocampus
    Evelin Vadas, Antonio J. López-Gambero, Antonio Vargas, Miguel Rodríguez-Pozo, Patricia Rivera, Juan Manuel Decara, Antonia Serrano, Stella Martín‐de‐las‐Heras, Fernando Rodrı́guez de Fonseca, Juan Suárez · 2025 · Biomolecules
  30. Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation
    Mario Pérez‐Diego, Alba Angelina, Yağız Pat, Angel E. Maldonado, Carmen Sevilla‐Ortega, Leticia Martín‐Cruz, Duygu Yazıcı, Beate Rückert, Milena Sokołowska, Mar Martín‐Fontecha et al. · 2025 · Journal of Allergy and Clinical Immunology
  31. Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity
    Beatriz Pacheco-Sánchez, Rubén Tovar, Meriem Ben Rabaa, Lourdes Sanchez Salido, Antonio Vargas, Juan Suárez, Fernando Rodrı́guez de Fonseca, Patricia Rivera · 2023 · International Journal of Molecular Sciences
  32. Cannabis sativa as an Herbal Ingredient: Problems and Prospects
    Ayodeji O. Oriola, Pallab Kar, Adebola Omowunmi Oyedeji · 2024 · Molecules
  33. Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
    Phannicha Kosukwatthana, Oumaporn Rungsuriyawiboon, Jatuporn Rattanasrisomporn, Kanogwan Kimram, Natthasit Tansakul · 2024 · Animals
  34. Cardiac sudden death in a young cannabis user
    Shogo Kasuda, Takeshi Kondo, Ikuko Terazawa, Mami Morimoto, Katsuya Yuui, Risa Kudo · 2021 · Legal Medicine
  35. Classical and Unexpected Effects of Ultra-Micronized PEA in Neuromuscular Function
    Pierangelo Cifelli, Gabriele Ruffolo, Marco Ceccanti, Chiara Cambieri, Laura Libonati, Eleonora Palma, Maurizio Inghilleri · 2022 · Biomolecules
  36. El sistema cannabinoide en situaciones de neuroinflamación: perspectivas terapéuticas en la esclerosis múltiple
    Leyre Mestre, Fernando Correa, Fabián Docagne, Diego Clemente, Silvia Ortega‐Gutiérrez, Ángel Arévalo‐Martín, Eduardo Molina‐Holgado, José Borrell Andrés, Carmen Guaza Rodríguez · 2006 · Revista de Neurología
  37. Cannabinoids for the treatment of neuroinflammation
    Maria L. DE CEBALLOS · 2015 · Elsevier eBooks
  38. Targeting the Endocannabinoid System to Treat Sepsis
    Joel Sardinha, Christine Lehmann, Melanie E. M. Kelly · 2013 · Signa Vitae
  39. Neuroprotection Strategies for Term Encephalopathy
    Fernando F. Gonzalez · 2019 · Seminars in Pediatric Neurology
  40. Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
    Nicholas T. Vozoris, Zhan Yao, Ping Li, Peter C. Austin, Anne L. Stephenson, Sudeep S. Gill, Denis E. O’Donnell, Andrea S. Gershon, Paula A. Rochon · 2019 · Drugs & Aging
  41. Efectos de una dieta hipocalórica rica en proteína/baja de hidratos de carbono vs. una estándar sobre los parámetros antropométricos y factores de riesgo cardiovascular, papel del polimorfismo rs3123554 del gen del receptor canabinoide tipo 2 (CB2R)
    David Primo, Olatz Izaola, Daniel Antonio de Luis · 2019 · Endocrinología Diabetes y Nutrición
  42. Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor
    Meirambek Ospanov, Suresh Ponnayyan Sulochana, Jason J. Paris, John M. Rimoldi, Nicole M. Ashpole, Larry Walker, Samir Anis Ross, Abbas Gholipour Shilabin, Mohamed A. Ibrahim · 2022 · Molecules
  43. Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
    Jie Xiao, Yue Zhou, Luqiang Sun, Haichuan Wang · 2023 · Frontiers in Molecular Neuroscience
  44. Targeting Astrocytomas and Invading Immune Cells with Cannabinoids: A Promising Therapeutic Avenue
    Eiron Cudaback, Nephi Stella · 2007 · Molecular Neurobiology
  45. Cannabinoids in multiple sclerosis: urgent need for long term trials
    Joep Killestein · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  46. Cannabidiol perturbs macrophage polarization by interfering with the metabolic flux and PI3K/Akt pathway
    Thadaphong Sukdee, Benjawan Wongprom, Patarakarnkul Thitiporn, Asada Leelahavanichkul, Awirut Charoensappakit, Kritsanawan Sae‐khow, Phanomsak Yukhet, Tirayut Vilaivan, Tanapat Palaga · 2025 · Scientific Reports
  47. Medical Cannabis Increases Appetite but Not Body Weight in Patients with Inflammatory Bowel Diseases
    Naomi Fliss Isakov, Chen Seidenberg, David Meiri, Michal Yackobovitch‐Gavan, Nitsan Maharshak, Ayal Hirsch · 2023 · Nutrients
  48. Pathophysiology of Portal Hypertension
    Manuel Morales‐Ruiz, Juan Rodríguez‐Vita, Jordi Ribera, Wladimiro Jiménez · 2014 · Springer eBooks
  49. Cannabinoids and Pain: Mechanisms of Action
    Samer Narouze · 2021 · Springer eBooks
  50. The role of endocannabinoids in the control of eating disorders
    Walter Milano, Mario Felice Tecce, Anna Capasso · 2017 · Diseases and Disorders
  51. PET Imaging of the Endocannabinoid System
    Garth E. Terry, Vanessa Raymont, Andrew G. Horti · 2020 · Springer eBooks
  52. Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening
    Fengmin Xiong, Xiaoyu Ding, Hao Zhang, Xiaomin Luo, Kaixian Chen, Hualiang Jiang, Cheng Luo, Heng Xu · 2021 · Bioorganic & Medicinal Chemistry Letters
  53. Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches
    Vid Ravnik, Marko Jukič, Veronika Furlan, Uroš Maver, Jan Rožanc, Urban Bren · 2025 · Frontiers in Pharmacology
  54. Investigation of Cannabidiol's Protective Effects on Cadmium‐Induced Toxicity in Mice
    Serkan Şahin, Tülay Mortaş, Ahmet Müderrisoğlu, Vugar Ali Türksoy · 2025 · Basic & Clinical Pharmacology & Toxicology
  55. EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines
    Bin Xu, Xiangnan Liang, Wuguang Liu, Biao Wu, Qiuxiang Wang, Gong Kai, Chun Han, Binwen Sun, Bing Dong, Chengyong Dong et al. · 2025 · Hereditas
  56. The Endocannabinoid System in Human Physiology
    Rosanna Chianese, Rosaria Meccariello · 2016 · InTech eBooks
  57. Cannabinoid receptors modulate LPS-induced increase of class-II transactivator expression levels in a microglial cell line
    Fatma Nihan Çankara, Zülfinaz Betül Çelik, Caner Günaydın · 2021 · Journal of Receptors and Signal Transduction
  58. The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
    Brock K. Bakewell, Matthew Sherman, Kimberly Binsfeld, Asif M. Ilyas, Stephen A. Stache, Saloni Sharma, David S. Stolzenberg, Ari C. Greis · 2022 · Cureus
  59. Cannabis Use is Associated with Less Peripheral Inflammation but Similar Insulin Sensitivity as Nonuse in Healthy Adults
    Angela D. Bryan, Carillon J. Skrzynski, G Giordano, Jinqiu Yang, Madeline Stanger, L. Cinnamon Bidwell, Kent E. Hutchison, Leigh Perreault · 2025 · The American Journal of Medicine
  60. Endocannabinoids and reproductive biology
    Mauro Maccarrone · 2009 · Human Reproduction
  61. Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation
    Thomas Tüting, Evelyn Gaffal · 2017 · Elsevier eBooks
  62. Common polymorphism in the cannabinoid receptor gene type 2 (CB2R) rs3123554 are associated with metabolic changes after two different hypocaloric diets with different dietary fatty profiles
    R. Aller, David Primo, Olatz Izaola, Daniel Antonio de Luis · 2018 · Clinical Nutrition
  63. Corticosterone inhibits the expression of cannabinoid receptor‑1 and cannabinoid receptor agonist‑induced decrease in cell viability in glioblastoma cells
    Naotoshi Sugimoto, Hiroaki Ishibashi, Yoshibumi Ueda, Hiroyuki Nakamura, Akihiro Yachie, Takako Ohno‐Shosaku · 2019 · Oncology Letters
  64. Effects of a high protein/low carbohydrate low-calorie diet versus a standard low-calorie diet on anthropometric parameters and cardiovascular risk factors, role of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CBR2)
    David Primo, Olatz Izaola, Daniel Antonio de Luis · 2020 · Endocrinología Diabetes y Nutrición (English ed )
  65. Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
    Valentina F. Kitchigina · 2021 · Neuroscience and Behavioral Physiology
  66. Endocannabinoid system and its role in energy regulation
    Isabel Matias, Vincenzo Di Marzo · 2006 · Expert Review of Endocrinology & Metabolism
  67. In silico discovery of terpenoid metabolism in Cannabis sativa
    Luca Massimino · 2017 · F1000Research
  68. Does cannabis hold the key to treating cardiometabolic disease?
    Paul E. Szmitko, Subodh Verma · 2006 · Nature Clinical Practice Cardiovascular Medicine
  69. Differential mRNA expression of neuroinflammatory modulators in the spinal cord and thalamus of type 2 diabetic monkeys
    Huiping Ding, Norikazu Kiguchi, Shiroh Kishioka, Tao Ma, Christopher Michael Peters, Mei‐Chuan Ko · 2018 · Journal of Diabetes
  70. Lipid lowering agents to delay cognitive decline in Alzheimer's disease?
    F-E de Leeuw · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  71. Cannabinoid receptor ligands with potential therapeutic applications and mechanisms of action: a versatile natural therapeutic agent
    Shivendra Mani Tripathi, Sharda Sambhakar, Sudhanshu K. Mishra, Rishabha Malviya, Sathvik Belagodu Sridhar · 2025 · Journal of Asian Natural Products Research
  72. Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial
    Veeradej Pisprasert, Bungon Sripanichkulchai, Teerawat Khannongpho, Amonrat Jumnainsong, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Patnarin Pongkulkiat, Tippawan Onchan, Somdej Kanokmedhakul, Apichart So-ngern et al. · 2025 · Journal of Cannabis Research
  73. Cannabinoids for Pain Modulation in Orthopedic Surgery
    Garwin Chin, Brent A. F. Etiz, Ariana Marie Nelson, Philip K. Lim, John Alan Scolaro · 2022 · Orthopedics
  74. Sample Preparation Techniques for Analysis of Endocannabinoids in Biological Fluids and Tissues
    Demet Dinçel, Yasin Darı · 2024 · Critical Reviews in Analytical Chemistry
  75. An Approach to Textile Recognition
    Kar Seng · 2009 · InTech eBooks
  76. The Endocannabinoid System in Local and Systemic Inflammation
    Melanie E. M. Kelly, Christine Lehmann, Juan Zhou · 2017 · Colloquium Series on Integrated Systems Physiology From Molecule to Function
  77. Cannabinoids for Neurological Conditions
    Baye G. Williamson, Joli M. Jarboe, Christine Weaver · 2021 · Springer eBooks
  78. A review on the important phytochemicals and their role in psoriasis
    Ashish Kumar Pandey, Alok Kumar Shukla, Ramesh Chandra Dubey, Ravi Pratap · 2021 · Journal of Applied and Natural Science
  79. Cannabinoids
    Sulabha Sambhaji Lalsare · 2022 · Asian Journal of Pharmaceutical Research and Health Care
  80. Cannabinoids in the Treatment of Parkinson’s Disease
    Florin Gandor, Georg Ebersbach · 2017 · Neurology International Open
  81. Cannabinoids Involvement in Neurodegenerative Diseases
    Walter Milano, Anna Capasso · 2019 · Research Journal of Pharmacology
  82. Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis
    Martino Belvederi Murri, Riccardo Guglielmo, Alessio Zizzi, Angela Muscettola, Maria Giulia Nanni, Manuela Dall’Oro, Gianluca Serafini, Alberto Inuggi, Andrea Escelsior, Mario Amore et al. · 2026 · Brain Behavior and Immunity
  83. Immunomodulatory and anticancer effects of phytochemicals: A comprehensive analysis
    Mohamed Ashraf Eltokhy, Marina Curcic, Shadan Modaresahmadi, Shreyas Ramchandra Gaikwad, Ninh My La-Beck, Sanjay K. Srivastava · 2026 · Pharmacological Reviews
  84. Substance abuse and inflammation: consequences beyond the brain
    Liu Yang, Michael A. Wheeler · 2026 · Trends in Immunology
  85. Screening and simulation study of efficacious antiviral cannabinoid compounds as potential agents against SARS-CoV-2
    Mahima Devi, Vivek Yadav · 2025 · Journal of Molecular Structure
  86. A Preliminary Evaluation of the Comparative Efficacy of Gel-Based and Oil-Based CBD on Hematologic and Biochemical Responses in Dogs
    Wassana Puttharaksa, Rangsun Charoensook, Rongdej Tungtrakanpoung, Niramon Hoidokhom, Saowaluk Rungchang, Bertram Brenig, Sonthaya Numthuam · 2025 · Veterinary Sciences
  87. Kannabisz használata az onkológiában: tények és tévhitek
    Zsófia Kürönya, Tamás Martin, Kiss Edina, Mihály Dániel Szőnyi, Krisztina Bíró · 2020 · Orvosi Hetilap
  88. Cannabis in Dermatology
    Catherine Murer Antley, Reagan Anderson, Judith Margulies · 2020 · Springer eBooks
  89. A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
    Senthil Nathan Jayarajan, Joseph J. Meissler, Martin W. Adler, Toby K. Eisenstein · 2022 · Frontiers in Pharmacology
  90. Morphine at inflammatory experimental pain: A review
    Hugo F. Miranda, Viviana Noriega, Francisca Moreno, Fernando Sierralta, Ramón Sotomayor‐Zárate, Juan Carlos Prieto · 2022 · World Journal of Advanced Research and Reviews
  91. Anandamide and Other Acylethanolamides
    Stefania Petrosino, Vincenzo Di Marzo · 2009 · Springer eBooks
  92. A comparative histological study on the effect of exposure to the smoke leaf extract of tobacco nicotiana, cannabis sativa and datura stramonium on the lungs of sprague-dawley rats
    Adedayo Damilare Adekomi, Ahmad Adekilekun Tijani, Adam Moyosore Afodun, Khadijah Kofoworola Quadri · 2012 · Scientific Journal of Medical Science
  93. Medical Cannabis for the Treatment of Inflammatory Bowel Disease
    Adi Lahat · 2017 · Elsevier eBooks
  94. Synthesis of 3-Aroylindoles as Intermediates of Cannabimimetics and Elucidation of Their Physicochemical Properties
    Hideyo Takahashi, Koji Araki, Kosho Makino, Hidetsugu Tabata, Hiroshi Nakayama, Kei Zaitsu, Tetsuta Oshitari, Hideaki Natsugari · 2018 · Heterocycles
  95. El polimorfismo del gen del receptor cannabinoide subtipo 2 (CB2R) rs3123554 está asociado con los cambios metabólicos tras la derivación biliopancreática
    Daniel Antonio de Luis, Susana García Calvo, David Primo, Olatz Izaola, David Pacheco · 2018 · Endocrinología Diabetes y Nutrición
  96. The endocannabinoid system as a target for the treatment of neurological disorders
    Jim DeMesa, Giovanni Appendino, Gaetano Morello, Michael Peter Murray, Eduardo Muñóz · 2020 · Elsevier eBooks
  97. Глюкокортикоиды в нейровоспалении гиппокампа: доктор Джекилл и мистер Хайд
    Alexey P. Bolshakov, Л.В. Третьякова, А. А. Квичанский, Н. В. Гуляева · 2021 · Biochemistry (Moscow)
  98. A Review of Studies Assessing Cannabidiol’s (CBD) Therapeutic Action and Potentials in Respiratory Diseases
    Arwa Fairaq · 2021 · Medico-Legal Update
  99. Neuroimmunology of Atopic Dermatitis
    A. Steinhoff, Martin S. Steinhoff · 2009 · Springer eBooks
  100. Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling
    Stefan Almestrand, Xiao Wang, Åsa Jeppsson-Ahlberg, Marcus Nordgren, Jenny Flygare, Birger Christensson, Stephan Rössner, Birgitta Sander · 2015 · PeerJ